Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Why Does Inhaling Anesthetics Cause Unconsciousness?

By BiotechDaily International staff writers
Posted on 04 Apr 2012
Image: The effects of Halothane on lipid rafts (Photo courtesy of NIST).
Image: The effects of Halothane on lipid rafts (Photo courtesy of NIST).
A new study suggests that the answer to this age-old question may lie in the effect of anesthesia on the organization of lipids in the cell's outer membrane, potentially altering the ability to send signals along nerve cells.

Researchers at the US National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA) set out to find out how exactly inhaled anesthetics interact with protein ion channels--large proteins embedded in the relatively small lipid molecules forming the membrane--which are responsible for conducting electrical impulses along the myelin sheath of the nerve cells. They found that while a cell membrane is a highly fluid film made of many different kinds of lipid molecules, the region immediately surrounding an ion channel often consists of a single type of lipids that form a sort of "raft" that is more ordered and less fluid then the rest of the membrane.

When prior research demonstrated that disrupting these lipid rafts could affect a channel's function, the researchers conducted X-ray and neutron diffraction studies of a binary lipid membrane that demonstrated that halothane (at physiological concentrations) produces a pronounced redistribution of lipids between domains of different lipid types, as identified by different lamellar d-spacing and isotope composition. In contrast, dichlorohexafluorocyclobutane (F6), a halogenated nonanesthetic, does not produce such significant effects. According to the researchers, these findings demonstrate a specific effect of inhalational anesthetics on mixing phase equilibria of a lipid mixture. The study was published on February 21, 2012, in Langmuir.

“A better fundamental understanding of inhaled anesthetics could allow us to design better ones with fewer side effects,” concluded lead author Hirsh Nanda, PhD, and colleagues of the NIST Center for Neutron Research (NCNR). “How these chemicals work in the body is a scientific mystery that stretches back to the Civil War.”

Related Links:

US National Institute of Standards and Technology



WATERS CORPORATION

Channels

Genomics/Proteomics

view channel
Image: Exosomes loaded with catalase (shown in red) efficiently interact with neurons (shown in black) to protect them from the effects of Parkinson\'s disease (Photo courtesy of Dr. Elena Batrakova, University of North Carolina).

Exome Delivery of the Anti-Oxidant Catalase Reduces Parkinson's Disease Symptoms in Mouse Model

The exosome delivery of the antioxidant enzyme catalase was shown to dramatically reduce symptoms of Parkinson's disease (PD) in a mouse model. Exosomes are cell-derived vesicles that are present in... Read more

Drug Discovery

view channel
Image: Star-like glial cells in red surround alpha-beta plaques in the cortex of a mouse with a model of Alzheimer\'s disease (Photo courtesy of Strittmatter laboratory/Yale University).

Experimental Cancer Drug Reverses Symptoms in Mouse Model of Alzheimer's Disease

An experimental, but clinically disappointing drug for treatment of cancer has been found to be extremely effective in reversing the symptoms of Alzheimer's disease (AD) in a mouse model.... Read more

Lab Technologies

view channel
Image: The gene assembly robot, the GeneTheatre (Photo courtesy of Analytik Jena AG).

Genomic Research Laboratories Await New Compact Liquid Handling System

A small footprint benchtop liquid handler that automates multiple gene assembly tasks and associated procedures such as PCR setup is now available for use by biotech and genomic research laboratories.... Read more

Business

view channel

NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer

The University of Texas MD Anderson Cancer Center (Houston, TX, USA) and NanoString Technologies, Inc. (Seattle, WA, USA) will partner on development of a revolutionary new type of assay—simultaneously profiling gene and protein expression, initially aiming to discover and validate biomarker signatures for immuno-oncology... Read more
 

Events

27 May 2015 - 28 May 2015
02 Jun 2015 - 03 Jun 2015
15 Jun 2015 - 18 Jun 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.